Market revenue in 2023 | USD 432.4 million |
Market revenue in 2030 | USD 663.6 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Devices |
Fastest growing segment | Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Devices, Drugs |
Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.91% in 2023. Horizon Databook has segmented the Canada hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study published by Canada Statistics in August 2019, an estimated 4.6 million adults in the Canada suffer from mild hearing loss for speech frequency between 0.5 kHz and 4 kHz. To address the situation, market players in Canada are focusing on implementation of health campaigns along with new product launches and technological developments for hearing aids.
For instance, in March 2023, Widex Canada announced the launch of its new campaign to raise awareness about tinnitus. The company introduced a free e-book, which offers information about better management of tinnitus and its treatment.
Furthermore, in August 2022, GN Hearing announced the launch of an advanced hearing aid, ReSound OMNIA, in Canada. This newly introduced device is capable of reducing noise by 150%. Moreover, in August 2022, Unitron announced launch of its new Moxi B-RS hearing aids with cutting edge technology.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Canada hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account